Differential adaptation of REM sleep latency, intermediate stage and theta power effects of escitalopram after chronic treatment

Journal of Neural Transmission

Volumn 120, Issue 1, 2013, Pages 169-176

  Vas, Szilvia ^a   Kátai, Zita ^a   Kostyalik, Diána ^a   Pap, Dorottya ^a   Molnár, Eszter ^a   Petschner, Péter ^a   Kalmár, Lajos ^b   Bagdy, György ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

5 HT1A receptor; Chronic treatment; Escitalopram; Intermediate stage of sleep; Rapid eye movement (REM) sleep; SSRI

Indexed keywords

ESCITALOPRAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; LATENT PERIOD; MALE; MOTOR ACTIVITY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; REM SLEEP; THETA RHYTHM; TREATMENT DURATION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CITALOPRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EYE MOVEMENTS; MALE; RATS; RATS, WISTAR; REACTION TIME; SEROTONIN UPTAKE INHIBITORS; SLEEP, REM; THETA RHYTHM; TIME FACTORS; WAKEFULNESS;

EID: 84872316905     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0847-2     Document Type: Article

References (40)

1. Acsady L, Arabadzisz D, Katona I, Freund TF (1996) Topographic distribution of dorsal and median raphe neurons with hippocampal, septal and dual projection. Acta Biol Hung 47(1-4):9-19 (Pubitemid 126524691)
2. Bagdy G (1998) Serotonin, anxiety, and stress hormones. Focus on 5-HT receptor subtypes, species and gender differences. Ann NY Acad Sci 851:357-363 (Pubitemid 28370396)
3. Bagdy E, Harsing LG Jr (1995) The role of various calcium and potassium channels in the regulation of somatodendritic serotonin release. Neurochem Res 20(12):1409-1415 (Pubitemid 26029131)
4. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38(8):1083-1152. doi: S0028390899000106 (Pubitemid 29292403)
5. Blier P, De Montigny C, Azzaro AJ (1986) Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system. J Pharmacol Exp Ther 237(3):987-994 (Pubitemid 16088124)
6. Chaput Y, Blier P, de Montigny C (1986) In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J Neurosci 6(10):2796-2801 (Pubitemid 16026058)
7. Dumont GJ, de Visser SJ, Cohen AF, van Gerven JM (2005) Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects. Br J Clin Pharmacol 59(5):495-510. doi: BCP234210.1111/j.1365-2125. 2005.02342.x (Pubitemid 40632239)
8. Feige B, Voderholzer U, Riemann D, Dittmann R, Hohagen F, Berger M (2002) Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects. Neuropsychopharmacology 26(2):246-258. doi: S0893133X0100314110.1016/S0893-133X(01)00314-1 (Pubitemid 34093087)
9. Felton TM, Kang TB, Hjorth S, Auerbach SB (2003) Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Naunyn Schmiedebergs Arch Pharmacol 367(3):297-305. doi: 10.1007/s00210-002-0688-x (Pubitemid 36408012)
10. Filakovszky J, Gerber K, Bagdy G (1999) A serotonin-1A receptor agonist and an N-methyl-d-aspartate receptor antagonist oppose each others effects in a genetic rat epilepsy model. Neurosci Lett 261(1-2):89-92. doi: S0304-3940(99)00015-4 (Pubitemid 29100083)
11. Gauthier P, Arnaud C, Stutzmann JM, Gottesmann C (1997) Influence of zopiclone, a new generation hypnotic, on the intermediate stage and paradoxical sleep in the rat. Psychopharmacology (Berl) 130(2):139-143 (Pubitemid 27132759)
12. Gillin JC, Jernajczyk W, Valladares-Neto DC, Golshan S, Lardon M, Stahl SM (1994) Inhibition of REM sleep by ipsapirone, a 5HT1A agonist, in normal volunteers. Psychopharmacology (Berl) 116(4):433-436 (Pubitemid 24374243)
13. Gottesmann C, Gandolfo G, Arnaud C, Gauthier P (1998) The intermediate stage and paradoxical sleep in the rat: influence of three generations of hypnotics. Eur J Neurosci 10(2):409-414 (Pubitemid 28325464)
14. Graf M, Jakus R, Kantor S, Levay G, Bagdy G (2004) Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy. Neurosci Lett 359(1-2):45-48. doi: S030439400400166110.1016/j. neulet.2004.01.072 (Pubitemid 38446635)
15. Ivarsson M, Paterson LM, Hutson PH (2005) Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats. Eur J Pharmacol 522(1-3):63-71. doi: S0014-2999(05)00852-610.1016/j.ejphar.2005.08.050 (Pubitemid 41456651)
16. Kantor S, Jakus R, Bodizs R, Halasz P, Bagdy G (2002) Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift. Brain Res 943(1):105-111. doi: S0006899302026987 (Pubitemid 34671178)
17. Kantor S, Jakus R, Balogh B, Benko A, Bagdy G (2004) Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505. Br J Pharmacol 142(8):1332-1342. doi: sj.bjp.070588710.1038/sj.bjp.0705887 (Pubitemid 39178887)
18. Kantor S, Jakus R, Molnar E, Gyongyosi N, Toth A, Detari L, Bagdy G (2005) Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectra. J Pharmacol Exp Ther 315(2):921-930. doi: jpet.105.08641310.1124/jpet.105.086413 (Pubitemid 41500759)
19. Kitka TBG (2008) Effect of 5-HT2A/2B/2C receptor agonists and antagonists on sleep and waking in laboratory animals and humans. In: Monti JM, Pandi-Perumal SR, Jacobs BL, Nutt DJ (eds) Serotonin and sleep: molecular functional and clinical aspects. Birkhäuser Verlag, Switzerland, pp 387-414
20. Kitka T, Katai Z, Pap D, Molnar E, Adori C, Bagdy G (2009) Small platform sleep deprivation selectively increases the average duration of rapid eye movement sleep episodes during sleep rebound. Behav Brain Res 205(2):482-487. doi: S0166-4328(09)00471-910.1016/j.bbr.2009.08.004
21. Lader M, Andersen HF, Baekdal T (2005) The effect of escitalopram on sleep problems in depressed patients. Hum Psychopharmacol 20(5):349-354. doi: 10.1002/hup.694 (Pubitemid 41093937)
22. Landolt HP, de Boer LP (2001) Effect of chronic phenelzine treatment on REM sleep: report of three patients. Neuropsychopharmacology 25(5 Suppl):S63-S67. doi: S0893133X0100321910.1016/S0893-133X(01)00321-9 (Pubitemid 33000271)
23. Maudhuit C, Jolas T, Lainey E, Hamon M, Adrien J (1994) Effects of acute and chronic treatment with amoxapine and cericlamine on the sleep-wakefulness cycle in the rat. Neuropharmacology 33(8):1017-1025
24. Monaca C, Boutrel B, Hen R, Hamon M, Adrien J (2003) 5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice. Neuropsychopharmacology 28(5):850-856. doi: 10.1038/sj.npp.13001091300109
25. Neckelmann D, Bjorvatn B, Bjorkum AA, Ursin R (1996) Citalopram: differential sleep/wake and EEG power spectrum effects after single dose and chronic administration. Behav Brain Res 79(1-2):183-192 (Pubitemid 26308938)
26. Oswald I, Adam K (1986) Effects of paroxetine on human sleep. Br J Clin Pharmacol 22(1):97-99 (Pubitemid 17177211)
27. Owens MJ, Knight DL, Nemeroff CB (2001) Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 50(5):345-350. doi: S0006-3223(01)01145-3 (Pubitemid 32816947)
28. Popa D, Lena C, Alexandre C, Adrien J (2008) Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J Neurosci 28(14):3546-3554. doi: 10.1523/jneurosci.4006-07.2008
29. Sanchez C, Brennum LT, Storustovu S, Kreilgard M, Mork A (2007) Depression and poor sleep: the effect of monoaminergic antidepressants in a pre-clinical model in rats. Pharmacol Biochem Behav 86(3):468-476. doi: S0091-3057(07)00022-610.1016/j.pbb.2007.01.006 (Pubitemid 46466878)
30. Sharpley AL, Williamson DJ, Attenburrow ME, Pearson G, Sargent P, Cowen PJ (1996) The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology (Berl) 126(1):50-54 (Pubitemid 26238498)
31. Sommerfelt L (1990) Chronic zimeldine administration to cats: sustained increase of serotonergic effect as measured with sleep parameters. Pharmacol Toxicol 66(2):128-132 (Pubitemid 20105610)
32. Steiger A, Kimura M (2010) Wake and sleep EEG provide biomarkers in depression. J Psychiatr Res 44(4):242-252. doi: S0022-3956(09)00189-710.1016/j. jpsychires.2009.08.013
33. Tatsumi M, Groshan K, Blakely RD, Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340(2-3):249-258. doi: S0014-2999(97)01393-9 (Pubitemid 28022649)
34. Tissier MH, Lainey E, Fattaccini CM, Hamon M, Adrien J (1993) Effects of ipsapirone, a 5-HT1A agonist, on sleep/wakefulness cycles: probable post-synaptic action. J Sleep Res 2(2):103-109. doi: jsr002002103 (Pubitemid 23203437)
35. van Bemmel AL, van den Hoofdakker RH, Beersma DG, Bouhuys AL (1993) Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram. Psychopharmacology (Berl) 113(2):225-230 (Pubitemid 24001997)
36. Wade A, Friis Andersen H (2006) The onset of effect for escitalopram and its relevance for the clinical management of depression. Curr Med Res Opin 22(11):2101-2110. doi: 10.1185/030079906X148319 (Pubitemid 44789974)
37. Waugh J, Goa KL (2003) Escitalopram: a review of its use in the management of major depressive and anxiety disorders. CNS Drugs 17(5):343-362. doi: 1754 (Pubitemid 36469972)
38. Wilson S, Argyropoulos S (2005) Antidepressants and sleep: a qualitative review of the literature. Drugs 65(7):927-947 (Pubitemid 40663621)
39. Wilson SJ, Bailey JE, Rich AS, Adrover M, Potokar J, Nutt DJ (2004) Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram. Eur Neuropsychopharmacol 14(5):367-372. doi: S0924977X0300221910. 1016/j.euroneuro.2003.11.004 (Pubitemid 39141678)
40. Winokur A, Gary KA, Rodner S, Rae-Red C, Fernando AT, Szuba MP (2001) Depression, sleep physiology, and antidepressant drugs. Depress Anxiety 14(1):19-28. doi: 10.1002/da.1043 (Pubitemid 32801613)